Therapeutic benefit of the dual ALK/FAK inhibitor ESK440 in ALK-driven neuroblastoma
| Title: | Therapeutic benefit of the dual ALK/FAK inhibitor ESK440 in ALK-driven neuroblastoma |
|---|---|
| Authors: | Chugh, Seema a, b, 1, Tien, Jean C. a, b, 1, Hon, Jennifer a, b, Kenum, Carson a, b, Mannan, Rahul a, b, Cheng, Yunhui a, b, Li, Chi Chiang a, b, Taher, Zainab I. a, b, Delekta, Andrew D. a, b, Bawa, Pushpinder Singh a, b, Apel, Ingrid J. a, b, Miner, Stephanie J. a, b, Cao, Xuhong a, b, Mehra, Rohit a, b, Dhanasekaran, Saravana M. a, b, Qiao, Yuanyuan a, b, Mody, Rajen a, c, Chinnaiyan, Arul M. a, b, d, e, f, ⁎ |
| Source: | In Neoplasia February 2025 60 |
| Database: | ScienceDirect |
| ISSN: | 14765586 |
|---|---|
| DOI: | 10.1016/j.neo.2024.100964 |
| Published in: | Neoplasia |
| Language: | English |